Exome Asset Management’s Acrivon Therapeutics ACRV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-116,757
Closed -$817K 59
2024
Q3
$817K Buy
+116,757
New +$817K 0.55% 50